611 Biodistribution and shedding analysis following treatment with RP1 oncolytic immunotherapy in the skin cancer patients from the IGNYTE clinical trial

Milhem, M, VanderWalde, A, Bowles, T et al. (20 more authors) (2022) 611 Biodistribution and shedding analysis following treatment with RP1 oncolytic immunotherapy in the skin cancer patients from the IGNYTE clinical trial. In: Journal for ImmunoTherapy of Cancer. SITC 37th Annual Meeting (SITC 2022), 08-12 Nov 2022, Boston, USA. BMJ , A643-A643.

Metadata

Authors/Creators:
  • Milhem, M
  • VanderWalde, A
  • Bowles, T
  • Sacco, J
  • Olsson-Brown, A
  • Niu, J
  • Tsai, K
  • Chesney, J
  • Chmielowski, B
  • Samson, A ORCID logo https://orcid.org/0000-0002-3081-7850
  • Rhodes, T
  • In, G
  • Pavlick, A
  • Wise-Draper, T
  • Sanmamed, M
  • Kalbasi, A
  • Love, C
  • Clack, A
  • Hou, J
  • Bommareddy, P
  • Coffin, R
  • Middleton, M
  • Harrington, K
Copyright, Publisher and Additional Information: © Author(s) (or their employer(s)) 2022. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Published (online): 7 November 2022
  • Published: 7 November 2022
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 09 Jun 2023 13:26
Last Modified: 09 Jun 2023 13:26
Status: Published
Publisher: BMJ
Identification Number: https://doi.org/10.1136/jitc-2022-sitc2022.0611
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)